For millions of people, the journey to find an antidepressant that works is a frustrating trial-and-error process. A new study looked at the genetics of over 135,000 people who were prescribed these medications to understand why some people don't respond. The researchers found two new genetic locations associated with not responding to common antidepressants like SSRIs and SNRIs. They also found that the genetics of non-response were linked to other psychiatric traits and, in a negative way, to cognitive traits and feelings of well-being. The study used this genetic information to suggest some existing drugs that might be worth testing further for people who don't respond to first-line treatments. It's crucial to remember this is a genetic association study—it shows a link, not a cause. The findings are early and need to be confirmed. The drugs they highlighted are just candidates for future research, not proven solutions. This work helps map the complex biology behind treatment resistance, but it doesn't change how doctors prescribe antidepressants today.
Why do antidepressants fail for some people? New genetic clues emerge.
Photo by Dmytro Vynohradov / Unsplash
What this means for you:
Early genetic clues found for why antidepressants fail, but it's not a test yet. More on Major Depressive Disorder
Text-message CBT treatment reduced generalized anxiety disorder symptoms in young adults compared to wait-list control. Text Message Therapy Reduces Anxiety Symptoms in Young Adults
· May 1, 2026
Magnetic seizure therapy non-inferior to ECT for depression with better memory outcomes Magnetic therapy matches standard shock therapy for depression but spares memory
· May 1, 2026
Systematic review finds aerobic exercise improves executive function in adults with major depressive disorder Aerobic exercise improves thinking skills in adults with major depression
· May 1, 2026
Infrared Thermography of Acupoints Shows Correlation with Depression Severity in Adolescents Body heat scans could help diagnose teen depression
Frontiers · Apr 29, 2026